You are here

Home » Content

MİDE KARSİNOMU OLGULARINDA KÜRATİF REZEKSİYONUN ERKEN VE GEÇ SONUÇLARI

Journal Name:

  • Cerrahpaşa Tıp Dergisi

Publication Year:

  • 2003

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Despite recent advances in diagnosis and treatment, gastric carcinoma is still among the major causes of death in malignant diseases worldwide. The results of patients, whose underwent curative gastrectomy for gastric cancer at Cerrahpaşa Medical Faculty Department of General Surgery from 1989 to 1993, were analyzed, retrospectively. Design.- Clinical characteristics were retrieved from the records of patients who underwent curative gastrectomy for gastric cancer. Pathologic characteristics were determined from a detailed review of all available histopathologic slides and reports. Results.- One hundred fifty-four patients underwent curative resection during the study period in Cerrahpaşa Medical Faculty Department of General Surgery. Overall 5-year survival rate was 58%. The relationship between clinicopathologic variables and 5-year survival rate was evaluated by univariate and multivariate analysis. When a multivariate analysis with logistic regression of 5-year survival was performed, stage, grade, vascular/lymphatic/ perineural invasion, depth of tumor invasion, levels of metastatic nodes and number of metastatic nodes emerged as the statistically significant in cases of curative resection. Conclusion.- These results suggest that the most important role for clinicians treating gastric carcinoma should be early diagnosis and aggressive surgery, followed by detailed pathologic examination.
Bookmark/Search this post with
Abstract (Original Language): 
Tanı ve tedavide son gelişmelere rağmen dünyada gastrik karsinoma hala malign hastalıklardan ölümlerin ana sebepleri arasında yer alır. Bu çalışmada 1989-1993 yılları arasında Cerrahpaşa Tıp Fakültesi Genel Cerrahi Anabilim Dalı’nda gastrik karsinoma nedeniyle küratif gastrektomi uygulanan hastaların sonuçları retrospektif olarak analize edilmiştir. 154 hastaya küratif rezeksiyon yapıldı. Beş yıllık ortalama sürvi %58’dir. Klinikopatolojik parametreler ile 5 yıllık sağkalım oranı arasındaki ilişki tek değişkenli ve çok değişkenli analizler ile değerlendirildi. Beş yıllık sağ kalımın logistik regresyonu çok değişkenli analizlerle yapıldığında, stage, grade, vasküler/lenfatikli/perinöral invazyon, tümör invazyonu derinliği, metastatik lenf nodları seviyesi ve sayısı çalışmamızda istatistiksel olarak anlamlı bulunmuştur. Çalışmamızda sonuçlar, gastrik karsinomada klinisyenlere düşen en önemli görevin erken tanı koyma ve agresif cerrahi ile tedavinin yapılması gereğini göstermiştir.
FULL TEXT (PDF): 
PDF icon arastirmax-mide-karsinomu-olgularinda-kuratif-rezeksiyonun-erken-gec-sonuclari.pdf
  • 4
178-184
  • Turkish

REFERENCES

References: 

1. Holdstock G, Bruce S: Endoscopy and gastric cancer.
Gut, 1981; 22: 673-676.
2. Sakita T: Study on early gastric cancer throughout Japan.
Gastrointest Endosc, 1983; 25: 317-43.
3. Akoh JA, Sedgwick DM, Macintyne IMC: Improving
results in the treatment of gastric carcinoma: An 11-year
audit. Br J Surg, 1991; 78: 349-51.
4. Carrea P: Human gastric carcinogenesis: a multistep and
multifactorial process-First American Cancer Award
Lecture on cancer epidemiology and prevention. Cancer
Res, 1992; 52: 6733-6740.
5. Nakamura K, Ueyama T, Yao T: Pathology and
prognosis of gastric carcinoma. Cancer, 1992; 70: 1080-
87.
6. Roder J, Böttcher K, Siewert R, Busch R, Hermanek P:
Prognostic factors in gastric carcinoma. Cancer, 1993;
72: 2089-97.
7. Msika S, Chastoma C, Houry S, Lacaine F, Huguier M:
Lymph node involvement as the only prognostic factor in
curative respected gastric carcinoma: A multivariate
analysis. World J Surg, 1989; 13: 118-23.
8. Michelassi F, Takanishi DM, Pantalone D et al: Analysis
of clinicopathologic prognostic features in patients with
gastric adenocarcinoma. Surgery, 1994; 116: 804-10.
9. Shiu MH, Moore E, Samders M et al: Influence of the
extent of resection on survival after curative treatment of
gastric carcinoma: a retrospective multivariate analysis.
Arch Surg, 1987; 122: 1347-51.
10. Moriguchi S, Kamakura T, Odaka T et al: Clinical
features of the differentiated and undifferentiated types of
advanced gastric carcinoma: Univariate and multivariate
analyses. J Surg. Oncol, 1991; 48: 202-4.
11. Lauren P: The two histological main types of gastric
carcinoma: Diffuse and so-called intestinal type
carcinomas. An attempt at histo-clinical classification.
Acta Pathol Microbial Scand 1965: 64:31-49.
12. Hamilton SR, Aaltonen L: A pathology and genetics of
tumours of digestive system. World Health
Organisation(WHO): Classification of tumors, Lyon
IARCP Press: 2000: 38
13. Hermanek P, Sobin LH: UICC.TNM Classification of
malignant tumors, 4 th ed. 2 nd rev. Berlin: Soringer.
1982
14. Mantedl H: Chi-square tests with one degree of fredom:
Extension of the Mantel-Haenzel procedure. JAMA,
1963; 58: 609-16.
15. Kaplan E, Meier P: Nonparametric estimation from
ıncomplete observation. J Am Stat Assoc, 1958: 53457-
81.
16. Japanese Research Society for Gastric Cancer: The
general rules for the gastric cancer study in surgery and
pathology: Clinical classification. Jpn J Surgery, 1981;
11: 127-135.
17. Macintyre IMC, Akoh JA: Improving survival in gastric
cancer: review of operative mortality in English language
publications from 1970. Br J.Surg, 1991; 78: 773-78.
18. Oka M, Yoshino S, Hazama S, Shimoda K, Suzuki M:
Prognostic significance of regional lymph node reaction
after curative resection of advanced gastric cancer. Br J
Surg, 1992; 79: 1091-94.
19. Haugstvedt TK, Viste A, Eide GE, Söreide O: Norwegian
multicenter study of survival and prognostic factors in
patients undergoing curative resection for gastric cancers.
Br J Surg, 1993; 80: 475-478.
20. Ovaska J, Kruuna O, Saario I, Schröder T, Lempinen T:
Surgical treatment of gastric carcinoma. The Am J Surg,
1989; l58: 467-471.
21. Maehara Y, Moriguchi S, Yoshida M, Takahashi I:
Splenectomy does not correlate with length of survival in
patients undergoing curative total gastrectomy for gastric
cancer: Univariate and multivariate analysis. Cancer,
1991; 67: 3006-9.
22. Gabbert H.E, Meier S, Gerharz CD, Hommel G: Neue
histomorphologishe Prognoseparameter beim
Magencarcinom. Der Chirurg, 1992; 63: 647-655.
23. Maehara Y, Orita H, Okuyama T: Predictors of lymph
node metastasis in early gastric cancer. Br J. Surg, 1992;
79: 245-7.
24. Tanaka A, Watanabe T, Okura K, Yasutomi T: Perineural
invasion as a predictor of recurrence of gastric cancer.
Cancer, 1994; 73: 550-5.
25. Adachi Y, Kamakura T, Mori M, Maehara Y: Role of
lymph node dissection and splenectomy in node positive
gastric carcinoma. Surgery, 1994; 116: 837-41.
26. Wanebo HJ, Kennedy BJ, Winchester DP: Gastric
carcinoma: Does lymph node dissection alter survival? J
Am Coll Surg, 1996; 183: 616-624.
27. Gall FP, Hermanek P: Die systematische erweiterte
lymphknoten dissektion in derkurauiten therapie des
megancarcinomas. Der Chirurg, 1993; 64: 1024-31.
28. Kodama Y, Sugimachi K, Soejima K, Matsusaka T:
Evaluation of extensive lymph node dissection for
carcinoma of the stomach. World J Surg, 1981; 5: 241-
248.
29. Viste A, Suanes K, Janssen CW, Mantmann M:
Prognostic significance of radical lymphadenectomy in
curative resections for gastric cancer. Eur J Surg, 1994;
160: 497-502.
30. Arak A, Kull K: Factors influencing survival of patients
after radical surgery for gastric cancer. A regional study
CERRAHPAŞA TIP DERGİSİ Cilt (Sayı) 34 (4)
184
of 406 patients over a 10-year period. Acta Oncol 1994;
33: 913-920.
31. Manzoni G, Verlato G, Guglielmi A, Laterza E:
Prognostic significance of lymph node dissection in
gastric cancer. Br J Surg, 1996; 83: 1604-1607.
32. Lee WJ, Hsu FC, Shun CT, Lee PH, Yu S.C: Surgical
treatment of gastric carcinoma: The role of lymph node
dissection. J Formus Med Assoc, 1995; 94: 221-7.
33. Siewert JR, Kestlmeier R, Busch R, Busch R, Böttcher K,
Roder JD: Benefits of D2 lymph node dissection for
patients with gastric cancer and pNo and pN1 lmph node
metastases. Br J Surg, 1996; 83: 1144-47.
34. Griffith JP, Sue Ling HM, Martın I, Dixon MF:
Preservation surgery for gastric cancer. Gut, 1995; 36:
684-90.
35. Wanebo HJ, Kennedy BJ, Winchester DP: Role of
splenectomy in gastric cancer surgery: Adverse effect of
elective splenectomy on long-term survival. J Am Coll
Surg, 1997; 185: 177-184.

Thank you for copying data from http://www.arastirmax.com